pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 545 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 3
(cefepime + taniborbactam hydrochloride)
cefepime + taniborbactam hydrochloride
Pyuria
VenatoRx Pharmaceuticals Inc
0 catalysts
Phase 3
(cisplatin + vinblastine sulphate)
Dedifferentiated Liposarcoma
$INTSINTENSITY THERAPEUTICS, INC.
0 catalysts
Phase 3
(clarithromycin + clofazimine + rifabutin)
Crohn's Disease (Regional Enteritis)
$RDHLRedHill Biopharma Ltd.
0 catalysts
← prev
page 2 of 19
next →
131
Pain89
Neurology1
Phase 3
(coagulation factor II (human) + coagulation factor VII (human) + coagulation factor IX (human) + coagulation factor X (human) + Protein C (human))
Blood Coagulation
$TAKTAKEDA PHARMACEUTICAL CO LTD
0 catalysts
Phase 3
(cycloserine + lurasidone hydrochloride)
Cyclurad ((cycloserine [INN] + lurasidone hydrochloride))
Bipolar Disorder (Manic Depression)
$NRXPNRX Pharmaceuticals, Inc.
0 catalysts
Phase 3
(edetate disodium + ethyl alcohol + minocycline hydrochloride)
Mino-Lok ((edetate disodium + ethyl alcohol + minocycline hydrochloride))
Fungal Infections
$CTXRCitius Pharmaceuticals, Inc.
0 catalysts
Phase 3
(efgartigimod alfa + hyaluronidase (human recombinant))
Vyvgart Hytrulo ((efgartigimod alfa + hyaluronidase (human recombinant)-qvfc))
Idiopathic Inflammatory Myopathy (IIM)
$ARGXARGENX SE
0 catalysts
Phase 3
(gentamicin sulfate + paromomycin sulfate)
(gentamicin sulfate + paromomycin sulfate [USP])
Leishmaniasis
Walter Reed Army Institute of Research
0 catalysts
Phase 3
(indomethacin + ketotifen)
(indomethacin + ketotifen [INN])
Coronavirus Disease 2019 (COVID-19)
Sen-Jam Pharmaceutical Inc
0 catalysts
Phase 3
(islatravir + lenacapavir)
(islatravir + lenacapavir [INN])
Human Immunodeficiency Virus (HIV) Infections (AIDS)
$GILDGILEAD SCIENCES, INC.
0 catalysts
Phase 3
(ketamine + midazolam)
(ketamine [INN] + midazolam [INN])
Sedation
$HROWHARROW, INC.
0 catalysts
Phase 3
(ketamine + sufentanil)
(ketamine [INN] + sufentanil)
Pain
Cessatech A/S
0 catalysts
Phase 3
(neltependocel + Y-27632)
Vyznova (neltependocel [INN])
Corneal Edema
Aurion Biotech Inc
0 catalysts
Phase 3
(riboflavin + sodium iodide)
(riboflavin [INN] + sodium iodide [USP])
Keratoconus
Epion Therapeutics Inc
0 catalysts
Phase 3
4D-150
Wet (Neovascular / Exudative) Macular Degeneration
$FDMT4D Molecular Therapeutics, Inc.
0 catalysts
Phase 3
AD-109
(atomoxetine [INN] + oxybutynin)
Obstructive Sleep Apnea
Apnimed Inc
0 catalysts
Phase 3
AP-301
Hyperphosphatemia
Shanghai Alebund Pharmaceuticals Ltd
0 catalysts
Phase 3
ATSN-201
Unspecified Ophthalmological Disorders
Atsena Therapeutics Inc
0 catalysts
Phase 3
AVD-104
Dry (Atrophic) Macular Degeneration
Aviceda Therapeutics Inc
0 catalysts
Phase 3
AVMEL-1
Melanoma
AiVita Biomedical Inc
0 catalysts
Phase 3
AZD-1390
Recurrent Glioblastoma Multiforme (GBM)
$AZNASTRAZENECA PLC
0 catalysts
Phase 3
Amesanar
Venous Leg Ulcers (Crural Ulcer)
RHEACELL GmbH & Co KG
0 catalysts
Phase 3
B-244
Acne Vulgaris
AOBiome Therapeutics Inc
0 catalysts
Phase 3
BNT-113
Recurrent Head And Neck Squamous Cell Carcinoma
$BNTXBioNTech SE
0 catalysts
Phase 3
BRM-421
Keratoconjunctivitis Sicca (Dry Eye)
BRIM Biotechnology Inc
0 catalysts
Phase 3
Bria-IMT
BriaVax
Human Epidermal Growth Factor Receptor 2 Low Breast Cancer (HER2 Low Breast C…
$BCTXBriaCell Therapeutics Corp.
0 catalysts
Phase 3
CB-03154
Amyotrophic Lateral Sclerosis
Shanghai Zhimeng Biopharma Inc
0 catalysts
Phase 3
CM-AT
LUMINENZ-AT
Autism Spectrum Disorder (ASD)
Curemark LLC
0 catalysts
Phase 3
COVID/Influenza Combination Vaccine
Seasonal Influenza
$NVAXNOVAVAX INC
0 catalysts
Phase 3
CT-388
Obesity
F. Hoffmann-La Roche Ltd
0 catalysts